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 Glaucoma, characterized by progressive optic neuropa-
thy, is the second most common blinding disease in the world
[1]. Primary open angle glaucoma (POAG) is the most com-
mon form of glaucoma, and its etiology is unknown. It has
been known since 1997 that mutation of the myocilin gene
(also known as TIGR for trabecular meshwork-inducible glu-
cocorticoid response) can cause juvenile-onset open angle glau-
coma (JOAG) [2]. More than 70 mutations in the myocilin
gene contribute to the pathogenesis of approximately 3% of
familial autosomal dominant adult-onset open angle glaucoma
and a greater proportion of JOAG [3]. Among the identified
myocilin gene mutations, the Pro370Leu mutation (OMIM
601652; allelic variant .007) is responsible for one of the most
severe glaucoma phenotypes [4-7].
Myocilin is a 504 amino acid secreted glycoprotein that
is normally expressed in a number of ocular and nonocular
tissues; a high amount of the protein is detectable in the trabe-
cular meshwork (TM), which is involved in the regulation of
intraocular pressure (IOP) [8,9]. Myocilin is known to influ-
ence the biological and physiological properties of human tra-
becular meshwork (HTM) cells and tissue, implicating the
protein in intracellular matrix, extracellular matrix (ECM), and
cell-ECM functions. [10,11]. However, these or other roles
for mycocilin have not been confirmed. The wild-type form
of myocilin induces changes in stress fibers, focal adhesions
of HTM cells, and is involved in interactions with ECM mol-
ecules and matricellular signaling-like activities [9-14]. In
expression studies, myocilin has been observed to colocalize
with structures that are part of the secretory pathway includ-
ing the endoplasmic reticulum (ER), Golgi apparatus, and in-
tracellular vesicles [14-16], and associates with mitochondria
and cytoplasmic filaments [13,14].
The significance of mutant forms of mycilin in the patho-
genesis of glaucoma remains elusive. It has been suggested
that the myocilin gene mutation that causes POAG represents
a gain of function mechanism. [17-19]. A series of functional
assays for mutant myocilin have shown that mutant proteins
become insoluble in the detergent Triton X-100 and
nonsecretory, inhibiting secretion of the normal myocilin pro-
tein [14,15,20,21]. Pro370Leu mutant myocilin may repre-
sent a misfolded, highly aggregation-prone form of the pro-
tein, which accumulates in the ER of HTM cells, resulting in
abnormal HTM cells morphology and cell death [16]. The
Tyr437His mutant mouse model of open-angle glaucoma has
demonstrated that Tg mice exhibit pathological changes simi-
lar to phenotype in glaucoma patients, with the mutated
myocilin being nonsecreted and accumulated in HTM cell
cytoplasm, similar to the aforementioned cell culture experi-
ments [22]. Both in vitro and in vivo data strongly indicate
that the accumulation of mutant myocilin in the ER of HTM
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cells is necessary for development of myocilin-associated glau-
coma [15,16,20-22]. The influence of myocilin gene muta-
tions, in particular Pro370Leu, on the ER are unclear and need
to be investigated.
In eukaryotic cells, the ER is responsible for the synthe-
sis, modification, and delivery of proteins to their proper tar-
get sites [23]. ER alterations can alter protein folding, leading
to the accumulation of aberrant proteins in the ER. This, in
turn, activates a signaling response termed the ER stress re-
sponse, which includes induction of ER-resident molecular
chaperones and foldases to complete the folding process,
downregulation of the biosynthetic load of the ER through the
shut-off of protein synthesis, and increased clearance of un-
folded proteins from the ER through the upregulation of ER-
associated degradation (ERAD) [23,24]. There are multiple
implications of ER stress response in health and disease. Un-
der ER stress, aberrantly folded proteins can activate the ER
stress response to return the ER to its normal physiological
state. When this process does not remedy the stress situation,
pathology can result [24-26]. Indeed, the accumulation of
misfolded protein in ER caused by gene mutations is most
likely the central event in the initiation of cell death in some
diseases including autosomal-dominant diabetes and familial
Alzheimer’s disease-linked presenilin-1 (PS1) and the alter-
natively spliced form of the presenilin-2 gene lacking exon 5
(PS2V)-induced cell apoptosis by effect on ER stress response
[27-31]. ER and mitochondria collaborate in both physiologi-
cal and pathophysiological cell functions, indicating that the
gateways to cell death involve complex and coordinated in-
teractions between these two organelles [24,32].
Accumulation of mutant myocilin proteins in the ER of
HTM cells is pathogenic and induces cell death [15,16]. How-
ever, knowledge of the molecular mechanism underlying the
cellular toxicity of mutant myocilin and the link with ER is
scant. The present study was undertaken to further clarify the
molecular details of the role of Pro370Leu mutant myocilin.
We hypothesized that Pro370Leu mutant myocilin is misfolded
and compromises the ER as well as other organelles function,
leading to HTM cell dysfunction or death. Here, we report the
results of our examinations of the effect of Pro370Leu mutant
myocilin on the ER stress response and mitochondrial mem-
brane potential (∆ψm) of HTM cells.
METHODS
Human trabecular meshwork cell culture:  The eyes from 5
human donors were obtained from the Eye Bank of Zhongshan
Ophthalmic Center within 24 h of death due to automobile
accidents. After enucleation, all eyes were cut equatorially
behind the ora serrata. The ciliary body, iris, and lens were
removed, and the trabecular meshwork was dissected under a
microscope (X40). Excised trabecular meshwork explants were
placed at 37 °C in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with with 10% fetal bovine serum,
50 mg/ml penicillin, and 50 units/ml streptomycin. Outgrowth
of cells was observed after 1-3 weeks. Phase contrast micros-
copy confirmed that confluent cultures formed a monolayer
with the typical morphological characteristics of cultured hu-
man trabecular meshwork cells. HTM cells were collected with
0.25% trypsin for 1-2 min. HTM cells derived from 22-, 25-,
29-, 30-, and 32-year-old healthy donors were cultured using
a technique described by Polansky et al. [33]. HTM cells were
cultured in Dulbecco’s Modified Eagle’s Medium (Gibco,
Grand Island, NY) supplemented with 10% fetal bovine se-
rum, 50 units/ml penicillin, and 50 mg/ml streptomycin. For
experiments, the fourth- or fifth-passage HTM cells were plated
in six-well tissue culture dishes and allowed to grow to
subconfluence.
Plasmid construction:  The full-length myocilin cDNA
clone has been described by Wang and Johnson [34]. BamHI
and EcoRI restriction enzyme cleavage site were added to the
5' and 3' end of the myocilin cDNA by PCR. The obtained
fragment was cloned into a mammalian expression plasmid
(pcDNA3.1[+]; Invitrogen, Carlsbad, CA). We produced
Pro370Leu mutations with the QuikChange site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA), according to the
manufacturer’s instructions. The specific PCR primers for
Pro370Leu mutagenesis were as follows: 5'-CTA CCA CGG
ACA GTT CCT GTA TTC TTG GGG TGG CTA-3', 5'-TAG
CCA CCC CAA GAA TAC AGG AAC TGT CCG TGG TAG-
3'. The sequence of Pro370Leu mutant myocilin plasmid was
verified with the DNA sequencer to confirm both the correct
insertion and absence of undesirable mutations.
Cell transfection and induction of endoplasmic reticulum
stress:  Fourth- or fifth-passage HTM cells grown to about
80-85% confluence were transiently transfected with about
1.5 to 2.0 µg wild-type or Pro370Leu mutant myocilin ex-
pression plasmids using LipofectAMINE™ (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
After 6 h, the cells were washed once with culture medium,
and further cultured for 40 h. The efficiency of transfection
was estimated in cells transiently transfected with the
pcDNA3.1(+)/GFP vector by counting the percentage of GFP-
positive cells using flow cytometry analysis. The transfection
efficiency was about 38-43%. HTM cells were transfected with
pcDNA3.1(+) plasmid and used as a negative control. To in-
duce ER stress, HTM cells were stimulated with 2.5 µg/ml
tunicamycin (Tm; Sigma, St. Louis, MO), and cultured for 6
h. The control dishes were treated without Tm.
Reverse transcription polymerase chain reaction:  Total
cellular RNA was extracted from HTM cells using TRIzol re-
agent (Invitrogen Corp.) according to the manufacturer’s in-
structions. Purified RNA was reverse- transcribed with
SuperScriptTM One-Step RT-PCR System (Invitrogen Corp.)
using a GeneAmp PCR (Perkin Elmer, Shelton, CT). For a
semiquantitative analysis of the PCR product, we used a nor-
malization procedure according to the manufacturer’s instruc-
tions. We performed 30 cycles and used an annealing tem-
perature of 50 °C and 55 °C, respectively, for GRP78 and
GAPDH. Primer pairs for the gene-specific RT-PCR analyses
were as follows: human GRP78, forward primer 5'-GAC ATC
AAG TTC TTG CCG TT-3' and reverse primer 5'-CTC ATA
ACA TTT AGG CCA GC-3', and human GAPDH, forward
primer 5'-CGT ATT GGG CGC CTG GTC ACC-3' and re-
verse primer 5'-GGG ATG ATG TTC TGG AGA GCC C-3'
619[35,36]. The sizes of the RT-PCR products were 260 bp and
587 bp, respectively. Each experiment was repeated three
times. The density of GAPDH was used as an internal stan-
dard to normalize densitometry measurements of the gel bands.
Semiquantitative analysis was performed by Gel-Pro Analyzer
software. The statistical difference was analyzed by the
Student’s t test. Value was expressed as the mean±standard
deviation (SD), and was calculated from three independent
experiments. A p value less than or equal to 0.05 was consid-
ered statistically significant.
Western blot analysis:  After treatment, HTM cells were
washed with cold phosphate buffered saline (PBS; pH 7.4)
and lysed in 100 µl protein extraction reagent (Pierce, Rock-
ford, IL). After boiling for 5 min, the cell lysates were centri-
fuged at 4 °C for 10 min, then the supernatants were collected
and stored at -70 °C. Each sample (20 µg) was loaded onto
12% SDS-polyacrylamide gels and electrophoresed at 100 V
for 1 h. The resolved proteins were transferred electrically to
PVDF membranes and incubated with 0.5% skim milk in tris-
buffered saline containing 0.05% Tween 20 (TTBS) for 1 h.
The membrane was probed with goat polyclonal GRP78 anti-
body (1:500 final dilution, Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), rabbit antiphospho-eIF2α antibody (1:1000
final dilution, Cell Signaling Technology, Inc., Beverly, MA),
rabbit eIF2α antibody (1:1000 final dilution, Signaling Tech-
nology, Inc.), and developed with Phototope-HRP Western Blot
Detection System kit (Cell Signaling Technology, Inc.) ac-
cording to the manufacturer’s instruction. As an internal con-
trol, the levels of β-actin were examined on the same blot at
the same time. Each experiment was repeated three times.
Quantitative analysis of western blotting was performed us-
ing Gel-Pro Analyzer software. The statistical difference of
the data was determined by the Student’s t test.
Measurement of ∆ψm: To measure the ∆ψm of HTM, we
used the fluorescent probe JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-
tetraethylbenzimidazole carbocyanide iodide; Molecular
Probes, Eugene, OR) and followed a method described in ref-
erence [37]. Briefly, HTM cells (5x105) were collected by
trypsinization, washed in PBS, then incubated with 1.0 µg/ml
JC-1 for 15 min at 37 °C. Cells were pelleted at 200x g for 5
min, and washed in PBS, then analyzed immediately by flow
cytometry analysis, using a BD FACS Aria™ flow cytometer
and BD FACSDiVa software (Becton Dickinson, Mountain
View, CA). For complete depletion of ∆ψm (positive control),
the mitochondrial uncoupler, carbonyl cyanide 3-
chlorophenylhydrazone (CCCP; 50 µM), was used. Photomul-
tiplier settings were adjusted to detect green fluorescence
(λem=525 nm) of JC-1 monomer on the filter 1 (FL-1 detector)
and the red fluorescence (λem=590 nm) of JC-1 aggregates on
the filter 2 (FL2 detector). In each experiment, at least 10,000
events were analyzed. The relative aggregate:monomer
(red:green) fluorescence intensity values were used for data
presentation. The statistical difference of the data was deter-
mined by the Student’s t test.
RESULTS
Effect of Pro370Leu mutant myocilin on the expression of glu-
cose-regulated protein78:  The wild-type and Pro370Leu mu-
tant myocilin plasmids were transiently transfected into HTM
cells for 48 h. The overexpression levels of the wild and mu-
tant myocilin mRNA were similar, which increased approxi-
mately sixfold compared with that of control by
semiquantitative PCR analysis (data not shown). The 78 kDa
glucose-regulated protein (GRP78) is known to be a key
marker of ER stress. When HTM cells were stimulated with
2.5 µg/ml Tm for 6 h to induce ER stress via prevention of
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Figure 1. Expression of glucose-regulated protein 78 mRNA in human trabecular meshwork cells.  A: Primary cultured human trabecular
meshwork (HTM) cells were either exposed to 2.5 µg/ml Tm for 6 h or not treated. B: Primary cultured HTM cells were transiently transfected
with the indicated expression plasmids. C: Primary cultured HTM cells were transiently transfected with the indicated expression plasmids,
then cells were exposed to 2.5 µg/ml Tm for 6 h. Total RNA was isolated from each cell population, and subjected to RT-PCR for glucose-
regulated protein78 (GRP78) mRNA (upper panels) or GAPDH mRNA (lower panels). The gel was representative of three separate experi-
ments. The following terms were used: mock, cells transfected with pcDNA3.1(+) expression plasmid; wild, cells transfected with wild-type
myocilin expression plasmid; and P370L, cells transfected with Pro370Leu mutant myocilin expression plasmid.
620protein glycosylation, the level of GRP78 mRNA significantly
increased compared with that of control (Figure 1A). Corre-
spondingly, GRP78 mRNA in HTM cells expressing
Pro370Leu mutant myocilin exhibited a significant decrease
(65.5±2.0%, mean±SD, n=3, p less than or equal to 0.05) com-
pared to cells transfected with wild-type myocilin plasmid
(Figure 1B). To confirm that Pro370Leu mutant myocilin spe-
cifically inhibited GRP78 mRNA induction, we transiently
transfected HTM cells with each expression plasmids and then
treated the cells with Tm for 6 h. GRP78 mRNA was mark-
edly reduced (62.7±1.4%, mean±SD, n=3, p less than or equal
to 0.05) in Pro370Leu-mutant-transfected HTM cells compared
with wild type-myocilin-transfected HTM cells (Figure 1C).
The expression of GAPDH mRNA as an internal control didn’t
change in any of the cell populations. Furthermore, similar
expression levels of GRP78 protein in the transfected HTM
cells were confirmed using western blot analysis. GRP78 pro-
tein expression was decreased by 22.5±2.3% (mean±SD, n=3,
p less than or equal to 0.05) in HTM cells expressing
Pro370Leu mutant myocilin compared to transfectants of wild-
type myocilin plasmid (Figure 2), whereas there was no sig-
nificant difference in GRP78 protein expression between wild-
type-myocilin-transfected and pcDNA3.1(+)-transfected cells.
Altered activation of phospho-eIF2α by Pro370Leu mu-
tant myocilin:  To further investigate the effect of Pro370Leu
mutant myocilin on the regulation of ER stress response, we
analyzed the activation of phosphorylaton of the α subunit of
eukaryotic translation initiation factor 2 (eIF2α). Under ER
stress, the outcome of phosphorylation of eIF2α is the attenu-
ation of protein translation [24,38]. Western blot analysis of
HTM cells using an anti- phospho-eIF2α antibody revealed
the constitutive expression of phospho-eIF2α protein in un-
treated HTM cells and in HTM cells transfected with wild-
type myocilin or pcDNA3.1(+) plasmids (Figure 3). In HTM
cells expressing Pro370Leu mutant myocilin the level of
phospho-eIF2α protein was markedly diminished (30.6±2.6%,
mean±SD, n=3, p less than or equal to 0.05) compared with
HTM cells transiently transfected with wild-type myocilin
plasmid, although the total quantity of eIF2α was not appre-
ciably altered (Figure 3).
Analysis of ∆ψm in human trabecular meshwork cells:
To understand the effect of Pro370Leu mutant myocilin
on mitochondria function of HTM cells, we analyzed the
change of ∆ψm by flow cytometry analysis with the fluores-
cent probe JC-1. JC-1 is selectively taken up into mitochon-
dria and so is a reliable indicator of change in ∆ψm [37,39].
At hyperpolarized ∆ψm, JC-1 forms J aggregates in a rapidly
reversible manner, emitting red fluorescence. During depo-
larization of mitochondria, JC-1 leaks and consequently re-
duces dye concentration in the mitochondrial matrix, and emits
a green fluorescence [40]. Ratiometric measurements of the
red to green JC-1 fluorescence indicates ∆ψm. Presently, the
staining pattern of JC-1 for normal HTM cells was established
as the standard. The scattergram (Figure 4A) revealed that the
highest number of cells presented in the R2 region with high
red fluorescence (FL-2) and high green fluorescence (FL-1).
When the HTM cells were transfected with Pro370Leu mu-
tant myocilin plasmid, the cells markedly decreased in the R2
region, whereas the cell population of the transfected cells in-
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Figure 2. Expression levels of glucose-regulated protein78 protein
in human trabecular meshwork cells.  Human trabecular meshwork
(HTM) cells were transfected with each expression plasmid
(pcDNA3.1(+), wild-type, Pro370Leu mutant myocilin plasmids) or
were treated with 2.5 µg/ml Tm. Untreated cells served as the con-
trol. Western blot was performed with an anti-glucose-regulated pro-
tein78 (GRP78) antibody and an anti-β-actin antibody. The blots are
representative of three experiments. The following terms were used:
mock, cells transfected with pcDNA3.1(+) expression plasmid; wild,
cells transfected with wild-type myocilin expression plasmid; and
P370L, cells transfected with Pro370Leu mutant myocilin expres-
sion plasmid.
Figure 3. Altered activation of phospho-eIF2α by Pro370Leu mutant
myocilin.  The phosphorylation of eIF2α was reduced in human tra-
becular meshwork (HTM) cells transiently transfected with
Pro370Leu mutant myocilin plasmid. The total eIF2α protein is shown
to demonstrate equal loading of lanes. β-Actin was used as an inter-
nal control. The blots are representative of three experiments. The
following terms were used: mock, cells transfected with pcDNA3.1(+)
expression plasmid; wild, cells transfected with wild-type myocilin
expression plasmid; and P370L, cells transfected with Pro370Leu
mutant myocilin expression plasmid.
621creased in the R4 region (Figure 4B). The change was the
consequence of a marked reduction in the percentage of
Pro370Leu-mutant-transfected HTM cells with normal ∆ψm
(mean±SD, 69.2±10.3% versus 92.5±12.7%; n=3, p less than
or equal to 0.05). Furthermore, the quantitative studies showed
the same results. The HTM cells expressing Pro370Leu mu-
tant myocilin had a lower ratio of red to green JC-1 fluores-
cence than normal HTM cells (mean±SD, 1.4±0.3 versus
2.9±0.3; n=3, p less than or equal to 0.05; Figure 5). The ∆ψm
of HTM cells transfected with wild-type myocilin or
pcDNA3.1(+) plasmids were similar to normal HTM cells (data
not shown).
DISCUSSION
 Missense mutations in myocilin that accumulate in large ag-
gregates in the ER of HTM cells lead to cell death [15,16].
However, the molecular mechanism causing the cellular tox-
icity of mutant myocilin is still unknown. This study provides
evidence that the Pro370Leu mutation in the myocilin gene,
which is known to produce severe disease phenotypes [4-7],
downregulates the signaling pathway of the ER stress response.
Under ER stress, genetic expression of ER molecular chaper-
ones is immediately induced, in which GRP78 is a central regu-
lator [24,41]. To determine the association between Pro370Leu
mutant myocilin and the ER stress response, we analyzed the
expression of GRP78 in HTM cells. We found the expression
of GRP78 in HTM cells is attenuated by Pro370Leu mutant
myocilin. This finding was unexpected, given the knowledge
that mutant myocilins, including G364V and Q368X, concen-
trate into punctate aggregates in the ER of HTM cells and
upregulate the expression of GRP78 [15]. We suggest the pos-
sible reason for the discrepancy between the previous and our
present results relates to differences in experimental condi-
tions such as methods of cell culture, and the myocilin mu-
tants studied. GRP78 induction under pathological conditions
may represent a major cellular protective mechanism for cells
to survive ER stress and thus has implications in organ preser-
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Figure 4. Analysis of ∆ψm in human trabecular meshwork cells.  A:
The scattergram showed the most cells presented in the R2 region
with high red fluorescence (FL-2) and high green fluorescence (FL-
1), which revealed normal ∆ψm of human trabecular meshwork
(HTM) cells. B: HTM cells transfected with Pro370Leu mutant
myocilin plasmid. The cells markedly decreased in the R2 region,
indicating that Pro370Leu mutant myocilin induced loss of ∆ψm. A
representative experiment of three is shown.
Figure 5. Quantification of ∆ψm in human trabecular meshwork cells
by JC-1.  A total of 5x105 normal and transfected human trabecular
meshwork (HTM) cells with Pro370Leu mutant myocilin plasmid
were analyzed by flow cytometry. A: Normal HTM cells. B: HTM
cells transfected with Pro370Leu mutant myocilin plasmid. Red fluo-
rescence (Red line) decreased in Pro370Leu-transfected HTM cells.
The reduction in the ratio of Red:green JC-1 fluorescence indicates
the drop of ∆ψm.
622vation [41,42]. Our findings indicate that the Pro370Leu mu-
tant myocilin downregulates the ER stress response and the
subsequent inhibition of GRP78 induction may weaken the
protein-folding machinery that normally detects and corrects
misfolded proteins. This downregulation of the ER stress re-
sponse by Pro370Leu mutant myocilin might perturb the pro-
tective mechanism, thus increasing the vulnerability of HTM
cells to ER stress. Such a mechanism is similar to the patho-
genic role of mutant PS1, which is linked to familial Alzheimer
Disease on the signaling pathway of unfolded protein response
[30,31].
Our results indicate that Pro370Leu mutant myocilin in-
hibits phosphorylation of eIF2α. During ER stress the phos-
phorylation of eIF2α plays an important role in attenuating
protein translation through the inhibition of the assembly of
the 80S ribosome [43,44]. In Eif2s1tm1Rjk mutant mice, the re-
duction in eIF2α phosphorylation leads to beta-cell failure and
type 2 diabetes. Phosphorylation of eIF2α is necessary to pre-
vent ER dysfunction and insulin secretion disorder [45]. There-
fore, we propose that the Pro370Leu mutant myocilin-medi-
ated loss of eIF2α phosphorylation increases the translation
of misfolded myocilin, which exceeds the ER folding capac-
ity, damages the structural functional integrity of the ER, and
predisposes HTM cells to failure. Alternatively, because trans-
lation attenuation is partially defective in HTM cells with
Pro370Leu mutant myocilin, misfolded myocilin might accu-
mulate in the ER rather than being transported to organelles,
such as the Golgi apparatus, plasma membrane, or ECM, which
could have an impact on its appropriate cellular/extracellular
function sites. Moreover, cells respond to ER stress by chang-
ing gene expression, selectively translating specific genes that
encode survival proteins through the phosphorylation of eIF2α
[43,44]. The production of the Pro370Leu mutant myocilin
inhibits the phosphorylation of eIF2α in the HTM cells, which
could impair this adaptive response and cell survival. Details
concerning the signaling regulation of ER stress response and
the function of missense-mutated myocilin remain to be elu-
cidated.
ER and mitochondria cooperate with each other in the
control of physiological cell function like metabolism, cal-
cium signaling, and in pathophysiological situations such as
cell death pathways [24,32]. In this study, we performed an
analysis to determine whether mitochondria play a role in the
HTM cell injury that is caused by Pro370Leu mutant myocilin.
We measured the change of ∆ψm in transfected HTM cells,
because ∆ψm is a highly sensitive indicator of the energetic
state of mitochondria and is an important monitor of key cel-
lular processes [39,40,46]. Flow cytometry analysis with the
fluorescent probe JC-1 revealed a decline of ∆ψm in HTM
cells transfected with a plasmid encoding Pro370Leu mutant
myocilin. Indeed, the depolarization of mitochondria may be
an early sign of mitochondrial dysfunction and may precede
many other signs of cell injury [39,47]. We suggest that
Pro370Leu mutant myocilin damages the mitochondrial func-
tion of HTM cells; collapse of ∆ψm probably causes disrup-
tion of the outer mitochondrial membrane, depletion of ATP,
and the release of damage factors. This remains to be con-
firmed, as does the Pro370Leu mutant myocilin-mediated
mitochondrial dysfunction of HTM cells.
Earlier studies have shown that the pathologic character-
istics of glaucoma include an increase in the accumulation of
extracellular material in the TM and a loss of TM cells. Our
present experiments demonstrate that Pro370Leu mutant
myocilin downregulates GRP78, inhibits the expression of
phosphorylation of eIF2α, and affects the ER stress response.
We suggest that the disturbed response may prolong ER stress
and change the secretory function of HTM cells, leading to an
altered extracellular environment and, ultimately, to HTM cell
dysfunction and death. Myocilin is localized to the mitochon-
dria of HTM cells, and dexamethasone treatment of HTM cells
increases myocilin-mitochondria association; moreover, pa-
tients with POAG display the greatest mitochondrial DNA
sequence alterations [12,13,46]. However, the relationship, if
any, between mutant myocilin and mitochondrial function has
not been reported. In the present study, we showed that
Pro370Leu mutant myocilin disturbs the ∆ψm of HTM cells.
Hence, we propose that mitochondrial dysfunction may be a
risk factor for HTM cell death caused by Pro370Leu mutant
myocilin.
In conclusion, the present data from our research demon-
strate that Pro370Leu mutant myocilin disturbs the protection
to ER stress and mitochondria function. We suggest that
Pro370Leu mutant myocilin causes perturbation of the ER
stress response and mitochondria dysfunction through a gain
of function, which is likely to render HTM cells more vulner-
able to secondary challenges such as oxidative stress and me-
chanical stretch, resulting in cell dysfunction or death. Our
study provides a framework for related mechanisms for mul-
tiple mutations of myocilin. Such a mechanism in glaucoma
might compromise the function of TM, increase outflow re-
sistance of aqueous humor, and ultimately lead to the disease.
This present study provides new insights into the relationship
between myocilin-associated glaucoma and the function of the
ER and mitochondria.
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